icon-folder.gif   Conference Reports for NATAP  
 
  64rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Washington, DC Nov 1-5 2013
Back grey_arrow_rt.gif
 
 
 
Safety, Tolerability, and Immunogenicity of GS-4774, an HBV-Specific Therapeutic Vaccine, in Healthy Volunteers
 
 
  Reported by Jules Levin
AASLD Nov 1-4 2013 Wash DC
 
Anuj Gaggar,1 Claire Coeshott,2 David Apelian,2 Tim Rodell,2 Gong Shen,1 Mani Subramanian,1 John McHutchison1
1Gilead Sciences, Inc., Foster City, CA; 2GlobeImmune, Louisville, CO

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif